Benjamin Hanfstein
Impact in
- Hematology top 0.5%
- Chronic Myeloid Leukemia Treatments
- Acute Myeloid Leukemia Research
- Genetics top 10%
- Myeloproliferative Neoplasms: Diagnosis and Treatment
Papers in
- Hematology 47
- Chronic Myeloid Leukemia Treatments 47
-
- Retinoids in leukemia and cellular processes 7
- Co-authors
- Andreas Hochhaus (22 shared papers)Rüdiger Hehlmann (10 shared papers)Nicholas C.P. Cross (2 shared papers)Sebastian Kreil (2 shared papers)Paul La Rosée (4 shared papers)Claudia Schoch (1 shared paper)Tanja Lahaye (1 shared paper)Harald Gschaidmeier (1 shared paper)
- Journals
- Blood (27 papers)Leukemia (8 papers)Annals of Hematology (6 papers)Leukemia Research (3 papers)Journal of Cancer Research and Clinical Oncology (3 papers)
- Partner nations
- GermanySwitzerlandAustralia
In The Last Decade
Benjamin Hanfstein
56 papers receiving 3k citations
Benjamin Hanfstein's Hit Papers
Peers
Comparison fields: 5 of 73
- Hematology 2.5k
- Genetics 69
- Oncology 141
- Family Practice 8
- Pathology and Forensic Medicine 54
Countries citing papers authored by Benjamin Hanfstein
This map shows the geographic impact of Benjamin Hanfstein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Benjamin Hanfstein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Benjamin Hanfstein more than expected).
Fields of papers citing papers by Benjamin Hanfstein
This network shows the impact of papers produced by Benjamin Hanfstein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Benjamin Hanfstein. The network helps show where Benjamin Hanfstein may publish in the future.
Co-authors
The 25 scholars most cited alongside Benjamin Hanfstein, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 56 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Molecular and chromosomal mechanisms of resistance to imatinib (STI571) therapy Hit paper breakdown → | 2002 | 753 |
| 2 | 2012 | 348 | |
| 3 | 2013 | 265 | |
| 4 | 2011 | 231 | |
| 5 | 2015 | 231 | |
| 6 | 2009 | 179 | |
| 7 | 2015 | 156 | |
| 8 | 2014 | 116 | |
| 9 | 2014 | 104 | |
| 10 | 2016 | 66 | |
| 11 | 2013 | 61 | |
| 12 | 2015 | 60 | |
| 13 | 2008 | 46 | |
| 14 | 2010 | 44 | |
| 15 | 2012 | 44 | |
| 16 | 2010 | 43 | |
| 17 | 2009 | 31 | |
| 18 | 2014 | 31 | |
| 19 | 2015 | 24 | |
| 20 | 2014 | 19 |
About Benjamin Hanfstein
Benjamin Hanfstein is a scholar working on Hematology, Molecular Biology, Oncology, Epidemiology and Genetics, having authored 56 papers that have together received 3.1k indexed citations. Recurring topics across this work include Chronic Myeloid Leukemia Treatments (47 papers), Retinoids in leukemia and cellular processes (7 papers), Multiple and Secondary Primary Cancers (2 papers), Genomic variations and chromosomal abnormalities (1 paper), Colorectal Cancer Surgical Treatments (1 paper) and Drug Transport and Resistance Mechanisms (1 paper). The work is most often cited by research in Hematology (2.5k citations), Genetics (69 citations), Oncology (141 citations), Family Practice (8 citations) and Pathology and Forensic Medicine (54 citations). Benjamin Hanfstein has collaborated with scholars based in Germany, Switzerland and Australia. Frequent co-authors include Andreas Hochhaus, Rüdiger Hehlmann, Nicholas C.P. Cross, Sebastian Kreil, Paul La Rosée, Claudia Schoch, Tanja Lahaye, Harald Gschaidmeier, Amie S. Corbin and Ute Berger. Their work appears in journals such as Blood, Leukemia, Annals of Hematology, Leukemia Research and Journal of Cancer Research and Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.